Skip to main content

Month: September 2024

Ultralife Corporation to Acquire Electrochem Solutions, Inc.

Acquisition to Drive Profitability through Increased Scale and Achievable Opportunities for Gross Margin Expansion NEWARK, N.Y., Sept. 30, 2024 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) has signed a stock purchase agreement to acquire all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) to include its state-of-the-art ISO certified technology and manufacturing facility for $50.0 million in cash from Integer Holdings Corporation (NYSE: ITGR), subject to customary working capital adjustments. The transaction is expected to close by the end of October. Ultralife expects to finance the transaction through its primary lender. Based in Raynham, MA and with over forty years of battery technology experience in critical applications, Electrochem designs and manufactures primary lithium metal and ultracapacitor...

Continue reading

AMN Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Thursday, November 7, 2024

DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2024 financial results and fourth quarter 2024 outlook on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare’s investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail address. A PIN will be provided to you with dial-in instructions. If you lose track of these details, please re-register at the conference call...

Continue reading

Provident Protection Plus Named a Top Performing Insurance Agency in the U.S. by the Independent Insurance Agents & Brokers of America

The insurance agency, serving businesses and consumers in New Jersey, New York, and Pennsylvania, was chosen out of 2,600 nominees as a leader in the industry AUGUSTA, NJ.., Sept. 30, 2024 (GLOBE NEWSWIRE) — Provident Protection Plus, a full-service insurance agency that offers comprehensive insurance programs to protect businesses, their employees, and consumers, has announced that it has retained its Best Practices status for 2024, joining an elite group of independent insurance agencies from across the U.S. The Best Practices agency designation is awarded to participants in the Best Practices Study, which analyzes and documents the business practices of the industry’s highest-performing insurance agencies. Over 2,600 independent agencies throughout the country were nominated for the selection process. For the 2024 study...

Continue reading

Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study

— Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment at week 14 — — Confirms the therapeutic benefits of PoNS Therapy for gait deficit improvement in people with MS — NEWTOWN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive preliminary results from its Therapeutic Experience Program open-label observational study (PoNSTEP) which evaluates the impact of subjects’ adherence to the Portable Neuromodulation Stimulator (PoNS®) Therapy program that treat gait deficit due to multiple sclerosis...

Continue reading

Matthews International Completes Senior Notes Offering

PITTSBURGH, Sept. 30, 2024 (GLOBE NEWSWIRE) — Matthews International Corporation (NASDAQ GSM: MATW) (“Matthews” or the “Company”) closed on September 27, 2024 on its previously announced private offering of $300 million aggregate principal amount of its 8.625% senior secured second lien notes due 2027 (the “Notes”). The Notes will pay interest semi-annually in arrears, on April 1 and October 1 of each year, beginning on April 1, 2025. The Notes will mature on October 1, 2027, unless earlier redeemed or repurchased, and are callable in one year. Mr. Bartolacci, President and Chief Executive Officer, stated: “We are pleased to complete the offering of our new notes, which will facilitate the repayment of our existing notes well in advance of their December 1, 2025 maturity and maintain the Company’s longstanding financial stability....

Continue reading

LOBO EV Technologies Ltd. Announces H1 2024 Earnings with 49% Revenue Growth and 45% Increase in Units Sold

WUXI, China, Sept. 30, 2024 (GLOBE NEWSWIRE) — LOBO EV Technologies Ltd. (NASDAQ: LOBO), (“LOBO” or the “Company”), an innovative e-bicycle, e-moped, e-tricycle, and electric off-highway four-wheeled shuttle designer, developer, manufacturer and seller, today announced its financial results for the six months ended June 30, 2024. H1 2024 Financial Highlights:Total Revenue: $12.13 million, up 49% compared to $8.14 million in H1 2023. Gross Profit: $1.36 million, reflecting a gross margin of 11.2%. Net Loss: $(0.31) million compared to net income of $0.67 million in H1 2023. Units Sold: 56,000 units, up 45% from 38,600 units sold in H1 2023. Adjusted EBITDA: Loss of $(0.09) million, compared to positive EBITDA of $0.44 million in the same period last year.Operational Performance: Sales from electric vehicles and accessories grew...

Continue reading

Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities

DURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced it has signed a contract to provide bioanalytical services for a publicly traded clinical-stage immuno-oncology company. This collaboration opens the door for further opportunities, as Scorpius expects to expand its services to include additional analytical work and future GMP manufacturing upon completion of this initial phase. This contract underscores Scorpius’ expertise in delivering critical bioanalytical and process development services, further establishing its role as a trusted partner in the biologics manufacturing space. Jeff Wolf, CEO of Scorpius, commented, “This important contract is...

Continue reading

Wellinks Acquires Spire Health Creating Industry Leader in Predictive Patient Care for Cardiopulmonary Health

Current customers and patients will continue with existing programs while integrated and enhanced solutions are expected in coming months NEW HAVEN, Conn., Sept. 30, 2024 (GLOBE NEWSWIRE) — Wellinks, the industry leader in virtual-led cardiopulmonary care, announced today it has acquired Spire Health in a non-cash transaction. The acquisition merges Spire’s novel patient monitoring technology with Wellinks highly specialized virtual-led cardiopulmonary care model creating a first of its kind fully integrated Predictive Patient Care company. As part of the agreement, Wellinks welcomes to the board of directors Mr. Rich Wilmot who will represent Spire’s majority investor Gilde Healthcare. “By combining these companies, we are now at the forefront of applying predictive analytics to the clinical care of cardiopulmonary patients,”...

Continue reading

Antelope Enterprise Announces First Half 2024 Financial Results

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), is the majority owner of Hainan Kylin Cloud Services Technology Co., Ltd (“Kylin Cloud”), the operator of a livestreaming ecommerce business in China, and the Company expects to shortly enter the energy field through the production of electricity in Texas using natural gas generators, today announced its financial results for the six months ended June 30, 2024. First Half 2024 SummaryRevenue generated from the livestreaming ecommerce business was $43.4 million, a 2.6% decrease as compared to $44.6 million for the same period of 2023. Gross profit generated from the livestreaming ecommerce business was $3.5 million, a 48.7% decrease as compared to $6.8 million for the...

Continue reading

Captivision Reports Half-Year Results for 2024

MIAMI and SEOUL, South Korea, Sept. 30, 2024 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneer manufacturer of architectural media glass and innovative LED solution provider, today reported financial results for the six months ended June 30, 2024, and provided a summary of recent financing and business activities. Half-year 2024 Financial Highlights and Recent Financing SummaryRevenue for half-year 2024 increased by 22% to $15.3 million compared to $12.6 million in the 2023 period Gross margin for half-year 2024 improved to 56% compared to 50% in the 2023 period Subsequent to the Company’s public listing late last year, Captivision raised approximately $8.3 million through equity and debt financings and converted approximately $4.2 million of outstanding debt into equity, further strengthening...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.